TRexBio · 4 weeks ago
Senior Scientist, Bioanalytical, Pharmacokinetics, and Immunology Assays
TRexBio is a clinical stage biotechnology company focused on developing revolutionary therapeutics for inflammatory diseases. The Senior Scientist will be responsible for assay development and optimization, collaborating with cross-functional teams to support preclinical programs and contributing to the advancement of the therapeutic pipeline.
BioinformaticsBiopharmaBiotechnology
Responsibilities
Design, develop, and execute assays to support PK/PD package of preclinical programs
Develop and optimize bioanalytical assays to quantify therapeutic proteins and biomarkers (e.g., ELISA, MSD)
Apply immunological techniques (e.g., flow cytometry, multiplex cytokine profiling) to characterize surface markers and immune cell states
Interpret and present data to cross-functional teams, contributing to dose-response and exposure–response modeling
Collaborate closely with discovery biology, in vivo pharmacology, and computational groups to advance pipeline candidates
Provide subject matter expertise in assay design, validation, and troubleshooting
Mentor junior scientists and contribute to team growth and best practices
Maintain detailed records in compliance with industry standards; support preparation of data packages for internal reviews and external partners
Qualification
Required
PhD in Immunology, Pharmacology, Biochemistry, or a related discipline with 3+ years of postdoctoral or industry experience; OR MS with 7+ years of biotech/pharma experience
Demonstrated expertise in bioanalytical assay development for therapeutic proteins
Strong technical proficiency in across immunoassay platforms and immune profiling techniques (e.g., ELISA, MSD, and flow cytometry)
Familiarity with immune cell surface marker analysis and characterization
Strong data analysis skills with the ability to communicate findings clearly across disciplines
Proven ability to work effectively in collaborative, fast-paced environments
Preferred
Experience with regulatory assay validation (GLP/GCLP) desirable but not required
Benefits
Discretionary Bonus
Company
TRexBio
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise.
Funding
Current Stage
Growth StageTotal Funding
$169MKey Investors
Delos CapitalPolaris Partners
2024-11-13Series B· $84M
2022-03-08Series A· $26M
2021-06-22Series A· $59M
Recent News
2025-09-04
Google Patent
2025-02-08
TRex Bio | Mapping a New Frontier in Immunobiology
2025-01-10
Company data provided by crunchbase